<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="116960-2018"
            EDITION="2018053">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-120923-001</RECEPTION_ID>
      <DELETION_DATE>20180416</DELETION_DATE>
      <FORM_LG_LIST>EN </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>53</NO_OJ>
         <DATE_PUB>20180316</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 053-116960</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="EN">http://ted.europa.eu/udl?uri=TED:NOTICE:116960-2018:TEXT:EN:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>EN</LG_ORIG>
         <ISO_COUNTRY VALUE="UK"/>
         <IA_URL_GENERAL>http://www.nhsscotlandprocurement.scot.nhs.uk/</IA_URL_GENERAL>
         <IA_URL_ETENDERING>https://www.publictendersscotland.publiccontractsscotland.gov.uk/esop/pts-host/public/pts/web/login.html</IA_URL_ETENDERING>
         <ORIGINAL_CPV CODE="33600000">Pharmaceutical products</ORIGINAL_CPV>
         <ORIGINAL_CPV CODE="33661000">Medicinal products for the nervous system</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="UKM">SCOTLAND</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="UKM">SCOTLAND</n2016:CA_CE_NUTS>
         <VALUES>
            <VALUE TYPE="ESTIMATED_TOTAL" CURRENCY="GBP">14800000</VALUE>
         </VALUES>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180315</DS_DATE_DISPATCH>
         <DT_DATE_FOR_SUBMISSION>20180416 12:00</DT_DATE_FOR_SUBMISSION>
         <AA_AUTHORITY_TYPE CODE="6">Body governed by public law</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="3">Contract notice</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="1">Open procedure</PR_PROC>
         <RP_REGULATION CODE="5">European Union, with participation by GPA countries</RP_REGULATION>
         <TY_TYPE_BID CODE="1">Submission for all lots</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="2">The most economic tender</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES>
         <HEADING>01B02</HEADING>
         <INITIATOR>01</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Обединено кралство</TI_CY>
            <TI_TOWN>Единбург</TI_TOWN>
            <TI_TEXT>
               <P>Фармацевтични продукти</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Spojené království/Velká Británie</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Léčivé přípravky a zdravotnické prostředky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Forenede Kongerige, Det</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Lægemidler</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>das Vereinigte Königreich</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Arzneimittel</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Ηνωμένο Βασίλειο</TI_CY>
            <TI_TOWN>Εδιμβούργο</TI_TOWN>
            <TI_TEXT>
               <P>Φαρμακευτικά προϊόντα</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>United Kingdom</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Pharmaceutical products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>Reino Unido</TI_CY>
            <TI_TOWN>Edimburgo</TI_TOWN>
            <TI_TEXT>
               <P>Productos farmacéuticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Suurbritannia / Ühendkuningriik</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Ravimid</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Yhdistynyt kuningaskunta</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Farmaseuttiset tuotteet</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>Royaume-Uni</TI_CY>
            <TI_TOWN>Édimbourg</TI_TOWN>
            <TI_TEXT>
               <P>Produits pharmaceutiques</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Ríocht Aontaithe, an</TI_CY>
            <TI_TOWN>Dún Éideann</TI_TOWN>
            <TI_TEXT>
               <P>Pharmaceutical products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Ujedinjena Kraljevina</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutski proizvodi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Egyesült Királyság</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Gyógyszerészeti termékek</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Regno Unito</TI_CY>
            <TI_TOWN>Edimburgo</TI_TOWN>
            <TI_TEXT>
               <P>Prodotti farmaceutici</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Jungtinė Karalystė, Didžioji Britanija</TI_CY>
            <TI_TOWN>Edinburgas</TI_TOWN>
            <TI_TEXT>
               <P>Farmacijos produktai</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Apvienotā Karaliste</TI_CY>
            <TI_TOWN>Edinburga</TI_TOWN>
            <TI_TEXT>
               <P>Farmācijas izstrādājumi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>Ir-Renju Unit</TI_CY>
            <TI_TOWN>Edinbugh</TI_TOWN>
            <TI_TEXT>
               <P>Prodotti farmaċewtiċi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>Verenigd Koninkrijk</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutische producten</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Zjednoczone Królestwo</TI_CY>
            <TI_TOWN>Edynburg</TI_TOWN>
            <TI_TEXT>
               <P>Produkty farmaceutyczne</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>Reino Unido</TI_CY>
            <TI_TOWN>Edimburgo</TI_TOWN>
            <TI_TEXT>
               <P>Produtos farmacêuticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Regatul Unit</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Produse farmaceutice</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Spojené kráľovstvo</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutické výrobky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Združeno kraljestvo</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Farmacevtski proizvodi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Förenade kungariket</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Läkemedel</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="EN">The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <NOTICE_UUID>1335958a-cc95-4382-88ca-ac881bf10211</NOTICE_UUID>
      <F02_2014 CATEGORY="ORIGINAL" FORM="F02" LG="EN">
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")</OFFICIALNAME>
               <ADDRESS>Gyle Square (NSS Head Office), 1 South Gyle Crescent</ADDRESS>
               <TOWN>Edinburgh</TOWN>
               <POSTAL_CODE>EH12 9EB</POSTAL_CODE>
               <COUNTRY VALUE="UK"/>
               <CONTACT_POINT>Stuart Gillespie</CONTACT_POINT>
               <PHONE>+44 1698794410</PHONE>
               <E_MAIL>stuart.gillespie@nhs.net</E_MAIL>
               <n2016:NUTS CODE="UKM"/>
               <URL_GENERAL>http://www.nhsscotlandprocurement.scot.nhs.uk/</URL_GENERAL>
               <URL_BUYER>http://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883</URL_BUYER>
            </ADDRESS_CONTRACTING_BODY>
            <CENTRAL_PURCHASING/>
            <DOCUMENT_FULL/>
            <URL_DOCUMENT>https://www.publictendersscotland.publiccontractsscotland.gov.uk/esop/pts-host/public/pts/web/login.html</URL_DOCUMENT>
            <ADDRESS_FURTHER_INFO_IDEM/>
            <URL_PARTICIPATION>https://www.publictendersscotland.publiccontractsscotland.gov.uk/esop/pts-host/public/pts/web/login.html</URL_PARTICIPATION>
            <CA_TYPE VALUE="BODY_PUBLIC"/>
            <CA_ACTIVITY VALUE="HEALTH"/>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT>
            <TITLE>
               <P>Glatiramer Acetate Injection</P>
            </TITLE>
            <REFERENCE_NUMBER>NP47818</REFERENCE_NUMBER>
            <CPV_MAIN>
               <CPV_CODE CODE="33600000"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>Framework Agreement for the supply of Glatiramer Acetate Injection in 20mg and 40mg presentations to Participating Authorities across NHS.</P>
               <P>Scotland.</P>
               <P>Supply will be made either directly to hospitals, patients in their own homes, or other designated delivery address, via a manufactured commissioned Home Delivery Service or to a home delivery supplier(s) as directed by the Participating Authorities and/or the Authority.</P>
            </SHORT_DESCR>
            <VAL_ESTIMATED_TOTAL CURRENCY="GBP">14800000</VAL_ESTIMATED_TOTAL>
            <LOT_DIVISION>
               <LOT_ALL/>
            </LOT_DIVISION>
            <OBJECT_DESCR ITEM="1">
               <TITLE>
                  <P>Glatiramer Acetate Injection including the provision of a manufacturer commissioned Home Delivery Service.</P>
               </TITLE>
               <LOT_NO>1</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33661000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="UKM"/>
               <MAIN_SITE>
                  <P>All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>This Lot is for the supply of 20 mg and 40 mg Glatiramer Acetate Injection direct to hospitals or direct to patients in their own home, or other designated address, via a manufacturer commissioned Home Delivery Service.</P>
                  <P>The Authority intends awarding this Lot as an unranked multi-supplier framework to a maximum of three (3) Framework Participants.</P>
                  <P>Additional information is available in the tender documentation.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Supply chain</AC_CRITERION>
                  <AC_WEIGHTING>5</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>95</AC_WEIGHTING>
               </AC_PRICE>
               <DURATION TYPE="MONTH">36</DURATION>
               <RENEWAL/>
               <RENEWAL_DESCR>
                  <P>The Authority is entitled at its sole discretion to extend the Framework Agreement by further periods of up to a maximum of twelve (12) months by giving a minimum of three (3) months written notice of such extension(s).</P>
               </RENEWAL_DESCR>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="2">
               <TITLE>
                  <P>Glatiramer Acetate Injection excluding a manufacturer commissioned Home Delivery Service</P>
               </TITLE>
               <LOT_NO>2</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33661000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="UKM"/>
               <MAIN_SITE>
                  <P>All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>This lot is for the supply of 20mg and 40mg glatiramer acetate injection direct to hospitals or nominated Home Delivery supplier(s) as directed by Participating Authorities and / or the Authority.</P>
                  <P>The Authority intends awarding this lot as an unranked multi-supplier framework to a maximum of three (3) Framework Participants.</P>
                  <P>Additional information is available in the tender documentation.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Supply chain</AC_CRITERION>
                  <AC_WEIGHTING>5</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>95</AC_WEIGHTING>
               </AC_PRICE>
               <DURATION TYPE="MONTH">36</DURATION>
               <RENEWAL/>
               <RENEWAL_DESCR>
                  <P>The Authority is entitled at its sole discretion to extend the Framework Agreement by further periods of up to a maximum of twelve (12) months by giving a minimum of three (3) months written notice of such extension(s).</P>
               </RENEWAL_DESCR>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
         </OBJECT_CONTRACT>
         <LEFTI>
            <SUITABILITY>
               <P>Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.</P>
            </SUITABILITY>
            <TECHNICAL_PROFESSIONAL_INFO>
               <P>Lot 1 and Lot 2:</P>
               <P>a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by approved by the MHRA for all tendered Medicines at the date of submission of the tender,</P>
               <P>b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.</P>
               <P>Lot 1 only:</P>
               <P>c) All of the goods supplied under the framework agreement must be stored in and distributed from a site holding an MHRA Wholesaler Dealers Authorisation which covers POM medicines,</P>
               <P>d) All of the dispensed Goods supplied under the framework agreement will be dispensed in a pharmacy which at the time of dispensing is registered with the General Pharmaceutical Council,</P>
               <P>(e) All of the Pharmacist and Pharmacy Technician staff used to service this framework agreement will be registered with the General Pharmaceutical Council,</P>
               <P>(f) The successful Framework Participant and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent,</P>
               <P>(g) All of the direct patient contact will be undertaken by staff, including all sub-contractors and couriers that, at the point of service provision, have Protecting Vulnerable Groups Scheme clearance in accordance with the prevailing regulations.</P>
            </TECHNICAL_PROFESSIONAL_INFO>
            <TECHNICAL_PROFESSIONAL_MIN_LEVEL>
               <P>Lot 1 and Lot 2:</P>
               <P>a) Confirmation of existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control,</P>
               <P>b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes.</P>
               <P>Lot 1 only:</P>
               <P>c) Confirmation of the storage and distribution site(s)’ MHRA Wholesaler Dealers Authorisation registration certificate, together with, in the event that the economic operator would sub-contract the storage and distribution of the medicines to any third party holder of such a certificate, a "To Whom It May Concern" letter from the certificate holder confirming that the certificate holder is (or intends to be) party to a contract with the economic operator in terms of which the certificate holder may be required by the economic operator to store and distribute all the medicines which NHS Scotland may require to be supplied in terms of the framework agreement,</P>
               <P>d) Confirmation of the dispensing site(s)’ General Pharmaceutical Council registration certificate, together with, in the event that the economic operator would sub-contract the dispensing of the medicines to any third party holder of such a certificate, a "To Whom It May Concern" letter from the certificate holder confirming that the certificate holder is (or intends to be) party to a contract with the economic operator in terms of which the certificate holder may be required by the economic operator to dispense all medicines which NHS Scotland may require to be dispensed in terms of the framework agreement,</P>
               <P>e) Confirmation of the Work Instructions and a description of the processes that would be in place to ensure all Pharmacists and Pharmacy Technicians employed to service this Framework Agreement were registered with the General Pharmaceutical Council,</P>
               <P>f) Confirmation of the existence of a valid certification of BS EN ISO 9001 or equivalent,</P>
               <P>g) Confirmation of Work Instructions and a description of the processes that would be in place to ensure all staff with direct patient contact had Protecting Vulnerable Groups Scheme clearance at the time of service provision.</P>
            </TECHNICAL_PROFESSIONAL_MIN_LEVEL>
         </LEFTI>
         <PROCEDURE>
            <PT_OPEN/>
            <FRAMEWORK>
               <SEVERAL_OPERATORS/>
               <NB_PARTICIPANTS>3</NB_PARTICIPANTS>
            </FRAMEWORK>
            <CONTRACT_COVERED_GPA/>
            <DATE_RECEIPT_TENDERS>2018-04-16</DATE_RECEIPT_TENDERS>
            <TIME_RECEIPT_TENDERS>12:00</TIME_RECEIPT_TENDERS>
            <LANGUAGES>
               <LANGUAGE VALUE="EN"/>
            </LANGUAGES>
            <DURATION_TENDER_VALID TYPE="MONTH">3</DURATION_TENDER_VALID>
            <OPENING_CONDITION>
               <DATE_OPENING_TENDERS>2018-04-16</DATE_OPENING_TENDERS>
               <TIME_OPENING_TENDERS>12:00</TIME_OPENING_TENDERS>
            </OPENING_CONDITION>
         </PROCEDURE>
         <COMPLEMENTARY_INFO>
            <NO_RECURRENT_PROCUREMENT/>
            <INFO_ADD>
               <P>The estimated values referred to in Section II.I.5 cover the thirty six (36) months contract duration and the twelve (12) month extension period of the framework agreement.</P>
               <P>The buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 10448. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343.</P>
               <P>The Contracting Authority does not intend to include a sub-contract clause as part of community benefits (as per Section 25 of the Procurement Reform (Scotland) Act 2014) in this contract for the following reason:</P>
               <P>It is not anticipated that sub-contractors will be used in delivery of this Framework Agreement.</P>
               <P>The Contracting Authority does not intend to include any community benefit requirements in this contract for the following reason:</P>
               <P>No Community Benefits will be deliverable through the award of this framework agreement.</P>
               <P>(SC Ref:535103).</P>
            </INFO_ADD>
            <ADDRESS_REVIEW_BODY>
               <OFFICIALNAME>The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")</OFFICIALNAME>
               <ADDRESS>Gyle Square (NSS Head Office), 1 South Gyle Crescent</ADDRESS>
               <TOWN>Edinburgh</TOWN>
               <POSTAL_CODE>EH12 9EB</POSTAL_CODE>
               <COUNTRY VALUE="UK"/>
               <PHONE>+44 1698794410</PHONE>
               <URL>http://www.nhsscotlandprocurement.scot.nhs.uk/</URL>
            </ADDRESS_REVIEW_BODY>
            <REVIEW_PROCEDURE>
               <P>The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information,</P>
               <P>A summary of the reasons why the economic operator was unsuccessful. The notification will incorporate a 'standstill period' of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority despatches the notice(s) and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the.</P>
               <P>Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.</P>
            </REVIEW_PROCEDURE>
            <DATE_DISPATCH_NOTICE>2018-03-15</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F02_2014>
   </FORM_SECTION>
</TED_EXPORT>
